SARRP 200 Small animal radiation research platform
SARRP 200 小动物辐射研究平台
基本信息
- 批准号:8826303
- 负责人:
- 金额:$ 59.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-03-23 至 2016-03-22
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAnimal ModelAnimalsBrain NeoplasmsChildComputer softwareComputersDevelopmentDevicesDimensionsFundingFutureHumanImmunologyLeadManualsMedicalMedical GeneticsModalityModelingMolecular VirologyMusNeurosciencesOhioPhysicsRadiationRadiation OncologyRadiation therapyResearchResearch InstituteResearch PersonnelRoentgen RaysRunningServicesSourceStagingSystemTechnologyTherapeuticTrainingTranslatingTubeUnited States National Institutes of HealthUniversitiesbasecone-beam computed tomographydesignimage guided radiation therapyimplantationinnovationinstrumentneurosurgerynew technologynext generationnovelprogramsranpirnasesealtreatment planningtumor
项目摘要
DESCRIPTION (provided by applicant): This shared instrument application is to support the purchase of a small animal radiation research platform (SARRP). The technology available from Xstrahl is unique and combines a cone beam CT with a computer controlled rotating treatment x-ray tube. In combination with the treatment planning software, this hardware allows for 3-dimensional radiotherapy treatment planning and delivery to model organisms that mimics the volumetric approach used to treat human tumors. This next-generation system leverages the recent advances in small animal CT to generate true image guided radiotherapy, or IGRT. The device incorporates a 360o rotating gantry with a stage that rotates and translates in 3 dimensions to allow for multiple x-ray beamlets to be delivered from any angle and converge upon the tumor. This system will replace the current technology at Ohio State University that is based on 50 year old design for cabinet X-ray machines. The cabinet x-ray device at Ohio State University is an RS2000, a point source X-ray generator fixed to the top of a sealed cabinet. In order to treat animals, one must use manual placement of lead shielding in such a way as to shield a portion of the mouse and allow x-ray delivery only to the model tumor. The SARRP will enhance the research of 6 major users with 9 currently funded NIH projects that span the departments of Radiation Oncology, Neurosurgery, and Molecular Virology, Immunology and Medical Genetics at OSUCCC and the Experimental Therapeutics program at Nationwide Children's Research Institute. In addition, the SARRP device will be incorporated into the training for the graduate program in medical physics run in the department of Radiation Oncology. Finally, the SARRP will be combined into the services that are offered at the OSU Neuroscience Center (P30) core for orthotopic brain tumor implantation. This core is designed to support the development of new technologies for the treatment of brain tumors. Current and future investigators using this core will now be able to incorporate radiotherapy with their novel modalities in the hope of generating innovative, synergistic therapeutics to treat brain tumors.
描述(由申请人提供):该共享仪器申请旨在支持购买小动物辐射研究平台 (SARRP)。Xstrahl 提供的技术是独一无二的,它将锥形束 CT 与计算机控制的旋转治疗 X 射线管结合在一起。与治疗计划软件相结合,该硬件可以进行 3 维放射治疗计划并交付给模型生物,模仿用于治疗人类肿瘤的体积方法。这种下一代系统利用小动物 CT 的最新进展来生成真实的放射治疗。图像该设备采用 360° 旋转机架,其平台可在 3 个维度上旋转和平移,以允许从任何角度发射多个 X 射线束并会聚在肿瘤上。该系统将取代当前的技术。俄亥俄州立大学基于 50 年前的柜式 X 射线机设计 俄亥俄州立大学的柜式 X 射线设备是 RS2000,一种固定在顶部的点源 X 射线发生器。为了治疗动物,必须手动放置铅屏蔽,以屏蔽小鼠的一部分,并仅允许 X 射线照射到模型肿瘤。 SARRP 将加强 6 的研究。目前资助的 9 个 NIH 项目涵盖 OSUCCC 的放射肿瘤学、神经外科、分子病毒学、免疫学和医学遗传学部门以及全国儿童研究所的实验治疗项目。此外,SARRP 设备将被纳入放射肿瘤学系医学物理学研究生课程的培训中,最后,SARRP 将被合并到 OSU 神经科学中心 (P30) 核心提供的原位服务中。该核心旨在支持治疗脑肿瘤的新技术的开发,当前和未来的研究人员现在将能够将放射治疗与他们的新方法结合起来,以期产生创新的、治疗脑肿瘤的协同疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas C. Denko其他文献
A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene
卡氏肺囊虫的 55 kDa 抗原:细胞免疫反应分析和基因表征
- DOI:
10.1111/j.1365-2958.1993.tb01165.x - 发表时间:
1993-03-01 - 期刊:
- 影响因子:3.6
- 作者:
Smulian Ag;S. Theus;Nicholas C. Denko;Peter D. Walzer;James R. Stringer - 通讯作者:
James R. Stringer
Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism.
p21Waf1/Cip1 的缺失通过一种不依赖细胞凋亡的机制使肿瘤对辐射敏感。
- DOI:
- 发表时间:
1997-11-01 - 期刊:
- 影响因子:11.2
- 作者:
B. Wouters;A. Giaccia;Nicholas C. Denko;Janice M. Brown - 通讯作者:
Janice M. Brown
A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy
p53 和 p21waf1 在肿瘤放射治疗反应中的独立作用
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:8
- 作者:
B. Wouters;Nicholas C. Denko;A. Giaccia;Janice M. Brown - 通讯作者:
Janice M. Brown
Nicholas C. Denko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas C. Denko', 18)}}的其他基金
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
- 批准号:
10737837 - 财政年份:2021
- 资助金额:
$ 59.97万 - 项目类别:
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
- 批准号:
10275968 - 财政年份:2021
- 资助金额:
$ 59.97万 - 项目类别:
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
- 批准号:
10704677 - 财政年份:2021
- 资助金额:
$ 59.97万 - 项目类别:
Diversity Supplement R01CA262388: Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
多样性补充剂 R01CA262388:通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
- 批准号:
10595436 - 财政年份:2021
- 资助金额:
$ 59.97万 - 项目类别:
Overcoming hypoxic resistance to anti-cancer therapy
克服抗癌治疗的缺氧抵抗
- 批准号:
10531898 - 财政年份:2020
- 资助金额:
$ 59.97万 - 项目类别:
Overcoming hypoxic resistance to anti-cancer therapy
克服抗癌治疗的缺氧抵抗
- 批准号:
10318987 - 财政年份:2020
- 资助金额:
$ 59.97万 - 项目类别:
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma
一项 0 期试点研究,以确定罂粟碱是否会增加自发性犬软组织肉瘤的氧合
- 批准号:
9985010 - 财政年份:2019
- 资助金额:
$ 59.97万 - 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
- 批准号:
8550788 - 财政年份:2012
- 资助金额:
$ 59.97万 - 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
- 批准号:
8703638 - 财政年份:2012
- 资助金额:
$ 59.97万 - 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
- 批准号:
9098620 - 财政年份:2012
- 资助金额:
$ 59.97万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
脆性X综合征动物模型中异常视觉信息处理和视觉注意力的神经环路机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds
利用新型静电纺丝支架开发细胞培养插入物和 3D 体外组织模型
- 批准号:
10697932 - 财政年份:2023
- 资助金额:
$ 59.97万 - 项目类别:
Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds
利用新型静电纺丝支架开发细胞培养插入物和 3D 体外组织模型
- 批准号:
10697932 - 财政年份:2023
- 资助金额:
$ 59.97万 - 项目类别:
Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics
人类类器官在基因组编辑治疗安全性和效率评估中的应用
- 批准号:
10667181 - 财政年份:2023
- 资助金额:
$ 59.97万 - 项目类别:
Effects of 16p11.2 copy number variation on neuronal development and pathology
16p11.2 拷贝数变异对神经元发育和病理学的影响
- 批准号:
10659523 - 财政年份:2023
- 资助金额:
$ 59.97万 - 项目类别:
Targeting Cholesterol Homeostasis to maintain vision in MS-like optic neuritis
针对多发性硬化症样视神经炎的胆固醇稳态以维持视力
- 批准号:
10657163 - 财政年份:2023
- 资助金额:
$ 59.97万 - 项目类别: